Newsroom
August 8, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
August 8, 2024
A drug effective in treating breast cancer shows new promise in addressing breast cancer with brain metastases or recurrent glioblastoma, as reported by results of a prospective window-of-opportunity trial at the University of Texas Health Science Center at San Antonio (UT Health San Antonio). The window trial, in which patients agreed to receive a novel […]
August 7, 2024
A researcher with (UT Health San Antonio) was awarded a $300,000 research project grant through the Texas Child Mental Health Care Consortium’s New and Emerging Children’s Mental Health Research initiative. Jessica Sandoval, MD, associate clinical professor with the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, in the Joe R. and […]
August 2, 2024
Luisa M. Rodriguez, MD, MS, clinical associate professor and pediatric endocrinology medical director, was quoted in this article. Read More
July 31, 2024
Scientists from The University of Texas Health Science Center at San Antonio, also known as UT Health San Antonio, led a pilot study of the Food and Drug Administration-approved antiretroviral drug lamivudine, to determine if it could be a potential treatment for Alzheimer’s disease. Almost half of what makes up the human genome are […]
July 31, 2024
A report released June 11 by the National Academies of Sciences, Engineering and Medicine (NASEM) provides a working definition of long COVID. Monica Verduzco-Gutierrez, MD, professor and chair of the Department of Rehabilitation Medicine in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San […]